Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have lymphedema (swelling caused by a build-up of lymph fluid) that developed as a result of breast cancer treatment
Who may not be able to join:
- People younger than 20 years old
- People who are currently pregnant
- People who have a heart device implanted in their body, such as a pacemaker, implantable defibrillator, or cardiac resynchronization therapy device
- People who have metal fragments inside their eyes
- People who have an implanted nerve stimulation device
- People who have a cochlear implant or bone-anchored hearing aid (confirm with trial site for specific conditions that may apply)
- People who have an implanted drug delivery pump, such as one used for insulin, pain medication, or chemotherapy (confirm with trial site, as removal of the device may be considered in some cases)
- People who have a catheter that contains metal parts, such as a Swan-Ganz catheter
- People who have metal fragments in their body, such as bullets, shotgun pellets, or metal shrapnel
- People who have surgical metal clips placed on a brain artery
- People who have magnetic dental implants
- People who have a tissue expander implanted in their body
- People who have an artificial limb
- People who use a hearing aid
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Li-Wei Kuo, Ph.D., National Health Research Institutes, Taiwan
Phone: +886-972653172
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
change from baseline circumference of both arms at 3 months after lymphaticovenous anastomosis; change from baseline volume of both arms at 3 months after lymphaticovenous anastomosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.